Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
45.20
+0.69 (1.55%)
Oct 22, 2026, 10:57 AM EDT - Market open
Boston Scientific Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 65,505 | 141,351 | 131,642 | 84,691 | 66,273 | 60,534 | |
Market Cap Growth | -55.45% | 7.38% | 55.44% | 27.79% | 9.48% | 17.59% |
Enterprise Value | 77,590 | 152,357 | 140,646 | 93,281 | 74,869 | 68,049 |
Last Close Price | 44.51 | 95.35 | 89.32 | 57.81 | 46.27 | 42.48 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.31 | 48.78 | 71.04 | 53.94 | 103.23 | 61.46 |
Forward PE | 14.04 | 28.71 | 33.08 | 26.76 | 24.51 | 23.73 |
PS Ratio | 3.07 | 7.04 | 7.86 | 5.95 | 5.23 | 5.09 |
PB Ratio | 2.58 | 5.78 | 5.98 | 4.34 | 3.77 | 3.64 |
P/FCF Ratio | 17.79 | 38.64 | 49.77 | 47.26 | 70.65 | 46.00 |
P/OCF Ratio | 14.24 | 31.18 | 38.32 | 33.84 | 43.43 | 32.37 |
PEG Ratio | 1.04 | 1.65 | 2.42 | 2.19 | 2.30 | 1.64 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.65 | 7.59 | 8.40 | 6.55 | 5.90 | 5.72 |
EV/EBITDA Ratio | 13.41 | 28.54 | 32.93 | 25.82 | 23.63 | 23.33 |
EV/EBIT Ratio | 17.82 | 38.37 | 46.85 | 38.59 | 36.83 | 37.31 |
EV/FCF Ratio | 21.13 | 41.65 | 53.17 | 52.05 | 79.82 | 51.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.50 | 0.49 | 0.51 | 0.49 | 0.53 | 0.57 |
Debt / EBITDA Ratio | 2.21 | 2.19 | 2.57 | 2.58 | 2.87 | 3.17 |
Debt / FCF Ratio | 3.48 | 3.27 | 4.25 | 5.34 | 9.96 | 7.24 |
Net Debt / Equity Ratio | 0.48 | 0.41 | 0.49 | 0.45 | 0.48 | 0.46 |
Net Debt / EBITDA Ratio | 2.12 | 1.87 | 2.53 | 2.41 | 2.66 | 2.61 |
Net Debt / FCF Ratio | 3.33 | 2.74 | 4.09 | 4.86 | 8.97 | 5.78 |
Asset Turnover | 0.48 | 0.48 | 0.45 | 0.42 | 0.39 | 0.38 |
Inventory Turnover | 2.12 | 2.18 | 2.00 | 2.02 | 2.30 | 2.54 |
Quick Ratio | 0.56 | 0.90 | 0.46 | 0.63 | 0.76 | 0.87 |
Current Ratio | 1.24 | 1.62 | 1.08 | 1.32 | 1.52 | 1.48 |
Return on Equity (ROE) | 15.34% | 12.45% | 8.88% | 8.58% | 4.08% | 6.52% |
Return on Assets (ROA) | 6.19% | 5.98% | 5.04% | 4.47% | 3.93% | 3.62% |
Return on Invested Capital (ROIC) | 11.20% | 10.08% | 7.95% | 7.15% | 4.95% | 7.43% |
Return on Capital Employed (ROCE) | 11.10% | 10.40% | 9.10% | 8.00% | 7.10% | 6.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.46% | 2.05% | 1.41% | 1.88% | 1.05% | 1.72% |
FCF Yield | 5.62% | 2.59% | 2.01% | 2.12% | 1.42% | 2.17% |
Payout Ratio | - | - | - | - | 7.88% | 5.28% |
Buyback Yield / Dilution | 0.05% | -0.58% | -1.53% | -1.65% | -0.41% | -1.21% |